Princeton, New Jersey3 days ago
D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.
We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.
At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals.
The Project Manager of Digital Health Technology (DHT) & eCOA will serve as a critical bridge between clinical operations, data management, clinical quality, and external technology partners, holding ultimate accountability for the successful implementation, quality, and compliance of patient-facing digital tools.